Capital International, Inc./CA/ - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 247 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
Capital International, Inc./CA/ ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$1,305,000
-16.7%
17,429
-3.7%
0.01%
-20.0%
Q4 2020$1,566,000
-41.3%
18,098
-58.6%
0.02%
-48.3%
Q3 2020$2,669,000
+203.0%
43,671
+106.2%
0.03%
+163.6%
Q2 2020$881,000
-89.2%
21,177
-92.5%
0.01%
-92.0%
Q1 2020$8,150,000
-58.0%
283,786
+5.6%
0.14%
-49.3%
Q4 2019$19,400,000
-48.1%
268,733
+0.9%
0.27%
-52.0%
Q3 2019$37,356,000
+1099.6%
266,280
+1465.7%
0.56%
+157.8%
Q2 2019$3,114,00017,0070.22%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders